Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)

A Miyata, L Jiang, RD Dahl, C Kitada, K Kubo… - Biochemical and …, 1990 - Elsevier
A Miyata, L Jiang, RD Dahl, C Kitada, K Kubo, M Fujino, N Minamino, A Arimura
Biochemical and biophysical research communications, 1990Elsevier
A novel neuropeptide with 38 residues (PACAP38) was isolated from ovine hypothalamic
tissues using the pituitary adenylate cyclase activation in rat pituitary cell cultures as a
parameter of the biological activity (Miyata et al, Biochem. Biophys. Res. Commun. 164, 567–
574, 1989). From the side fractions obtained during the purification of PACAP38, a shorter
form peptide with 27 residues corresponding to the N-terminal 27 amino acids of PACAP38
and amidated C-terminus was isolated and named as PACAP27. Synthetic PACAP27 …
Abstract
A novel neuropeptide with 38 residues (PACAP38) was isolated from ovine hypothalamic tissues using the pituitary adenylate cyclase activation in rat pituitary cell cultures as a parameter of the biological activity (Miyata et al, Biochem. Biophys. Res. Commun. 164, 567–574, 1989). From the side fractions obtained during the purification of PACAP38, a shorter form peptide with 27 residues corresponding to the N-terminal 27 amino acids of PACAP38 and amidated C-terminus was isolated and named as PACAP27. Synthetic PACAP27 showed a biological activity of adenylate cyclase stimulation comparable to PACAP38. Moreover PACAP27 which shows a considerable homology with vasoactive intestinal polypeptide (VIP) demonstrated a similar vasodepressor activity as VIP, but the adenylate cyclase stimulating activity was about 1000 times greater than VIP.
Elsevier